BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1000 related articles for article (PubMed ID: 10980691)

  • 1. Thyroid-associated eye disease.
    Heufelder AE; Joba W
    Strabismus; 2000 Jun; 8(2):101-11. PubMed ID: 10980691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis of ophthalmopathy in autoimmune thyroid disease.
    Heufelder AE
    Rev Endocr Metab Disord; 2000 Jan; 1(1-2):87-95. PubMed ID: 11704996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interactions of fibroblasts, adipocytes and immunocompeent cells in the pathogenesis of endocrine ophthalmopathy].
    Heufelder AE
    Acta Med Austriaca; 2001; 28(4):89-92. PubMed ID: 11593897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pathogenesis of Graves' ophthalmopathy].
    Heufelder AE
    Z Arztl Fortbild Qualitatssich; 1999 Apr; 93 Suppl 1():35-9. PubMed ID: 10355048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of the orbital fibroblast and TSH receptor in the pathogenesis of Graves' ophthalmopathy.
    Heufelder AE
    Thyroid; 1995 Aug; 5(4):331-40. PubMed ID: 7488878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular analysis of antigen receptor variable region repertoires in T lymphocytes infiltrating the intrathyroidal and extrathyroidal manifestations in patients with Graves' disease.
    Heufelder AE; Schworm HD; Wenzel BE; Garrity JA; Bahn RS
    Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 4():84-7. PubMed ID: 8981009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role od adhesion molecules in the pathogenesis of Graves ophthalmopathy].
    Kulig G; Pilarska K
    Klin Oczna; 2001; 103(2-3):147-50. PubMed ID: 11873415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of Graves' orbital fibroblast proliferation by cytokines and glucocorticoid receptor agonists.
    Heufelder AE; Bahn RS
    Invest Ophthalmol Vis Sci; 1994 Jan; 35(1):120-7. PubMed ID: 8300338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous T-lymphocytes stimulate proliferation of orbital fibroblasts derived from patients with Graves' ophthalmopathy.
    Feldon SE; Park DJ; O'Loughlin CW; Nguyen VT; Landskroner-Eiger S; Chang D; Thatcher TH; Phipps RP
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):3913-21. PubMed ID: 16249464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Detection, localization and modulation of hyaluronic acid/CD44 receptor expression in patients with endocrine orbitopathy].
    Heufelder AE; Bahn RS; Boergen KP; Scriba PC
    Med Klin (Munich); 1993 Apr; 88(4):181-4, 277. PubMed ID: 8492772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell restriction in thyroid eye disease.
    Heufelder AE
    Thyroid; 1998 May; 8(5):419-22. PubMed ID: 9623734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of glycosaminoglycan production in cultured human retroocular fibroblasts.
    Korducki JM; Loftus SJ; Bahn RS
    Invest Ophthalmol Vis Sci; 1992 May; 33(6):2037-42. PubMed ID: 1582808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence of limited variability of antigen receptors on intrathyroidal T cells in autoimmune thyroid disease.
    Davies TF; Martin A; Concepcion ES; Graves P; Cohen L; Ben-Nun A
    N Engl J Med; 1991 Jul; 325(4):238-44. PubMed ID: 1829139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrobulbar T cells from patients with Graves' ophthalmopathy are CD8+ and specifically recognize autologous fibroblasts.
    Grubeck-Loebenstein B; Trieb K; Sztankay A; Holter W; Anderl H; Wick G
    J Clin Invest; 1994 Jun; 93(6):2738-43. PubMed ID: 8201012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of expression of somatostatin receptor subtypes in Graves' ophthalmopathy orbits: relevance to novel analogs.
    Cozma I; Zhang L; Uddin J; Lane C; Rees A; Ludgate M
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1630-5. PubMed ID: 17848636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anatomy of the immune system: facts and problems.
    Grossi CE; Ciccone E; Tacchetti C; Santoro G; Anastasi G
    Ital J Anat Embryol; 2000; 105(4):97-124. PubMed ID: 11265217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral blood T lymphocyte sensitisation against calsequestrin and flavoprotein in patients with Graves' ophthalmopathy.
    Nguyen B; Gopinath B; Tani J; Wescombe L; Wall JR
    Autoimmunity; 2008 Aug; 41(5):372-6. PubMed ID: 18568642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine therapy of established tumors in the absence of autoimmunity.
    Hodge JW; Grosenbach DW; Aarts WM; Poole DJ; Schlom J
    Clin Cancer Res; 2003 May; 9(5):1837-49. PubMed ID: 12738742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyrotropin receptor expression in Graves' orbital adipose/connective tissues: potential autoantigen in Graves' ophthalmopathy.
    Bahn RS; Dutton CM; Natt N; Joba W; Spitzweg C; Heufelder AE
    J Clin Endocrinol Metab; 1998 Mar; 83(3):998-1002. PubMed ID: 9506762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathophysiology of Graves' ophthalmopathy.
    Stiebel-Kalish H; Robenshtok E; Gaton DD
    Pediatr Endocrinol Rev; 2010 Mar; 7 Suppl 2():178-81. PubMed ID: 20467359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.